Axia Pharmaceutical
Compounding Pharmacy
Based in CA
🤖
AI Overview
With $62K in lobbying spend across 8 quarterly filings, Axia Pharmaceutical is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.
$62K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $22K |
| 2019 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
- •Monitoring FDA Implementation of legislation affecting Compounding Pharmacies.
- •Monitoring FDA Implementation of legislation affecting Compounding Pharmacies
- •Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B) is in alignment with the statutory language. Legislation efforts include working
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.